Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
Date:11/6/2009

2,187,626 4,387,636 General and administrative 1,220,745 947,684 3,347,279 3,242,614 --------- ------- --------- --------- 1,847,285 3,371,627 5,735,307 8,175,829 Facility lease termination Gain from lease buyout - (4,100,000) - (4,100,000) Expenses related to relocation and lease buyout - 116,867 - 116,867 --------- ------- --------- --------- Total facility lease buyout - (3,983,133) - (3,983,133) --------- ------- --------- --------- Total operating (revenue) expenses 1,847,285 (611,506) 5,735,307 4,192,696 --------- ------- --------- --------- Income (loss) from operations (1,585,634) 847,814 (5,071,095) (3,411,261) Other income (expense) Interest income 948 45,858 12,060 205,530 Interest expense - (3,393) (3,512) (11,565) Other - 91 - 1,329 --------- ------- --------- --------- Total other income 948 42,556 8,548 195,294 --------- ------- --------- --------- Net income (loss) $(1,584,686) $890,370 $(5,062,547)$(3,215,967) ========= ======== ========= ========= Net income (loss) per share, basic and diluted $(0.04) $.02 $(0.12) $(0.08) ========= ======== ========= ========= Shares used in computing basic net income (lo
'/>"/>
SOURCE SCOLR Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
4. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
5. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
6. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
7. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
8. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
9. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis
10. Northern Light Adds 4,000 Bio-Pharma, Health Sciences and General Business News and Journal Sources from EBSCO Publishing
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Sept. 16, 2014 Research and Markets ... Market 2014-2018" report to their offering. ... of animals. Animal vaccines are generally prepared from weakened or ... their healthy state. Some of the animal vaccines are also ... protein subunits or toxic components. These components ...
(Date:9/16/2014)... 2014  Advanced Medical Isotope Corporation ("AMIC") ... engaged primarily in the development of brachytherapy ... therapeutic applications, today announced that a patent ... brachytherapy products.  AMIC,s rights for the newly ... Battelle, under which AMIC exclusively licensed technologies ...
(Date:9/16/2014)... TUCSON, Ariz. , Sept. 16, 2014 ... describe in a case report the first ... (TAH-t) in a 13- year-old boy with failing Fontan ... When he was 3 years old, the patient ... condition known as functional single ventricle. "The Fontan operation ...
Breaking Medicine Technology:Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 413-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 213-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 3
... breakthrough in mental health has been developed, a cooperative ... Foundation; a preventative care program called "Safe ,til Stable." ... time of need through our live 24-hour emergency response ... the trauma experienced by individuals impacted with bipolar disorder. ...
... A Chicago woman will be among the first in the country to, ... get rid of Gastrointestinal Esophageal Reflux Disease (GERD), ... transorally, through the mouth. ... the body, the doctor uses a device to, ...
Cached Medicine Technology:Break-through Preventative Care Program for People Living With Bipolar Disorder 2New Incision-Less Procedure for REFLUX - Experts Consider it to Be Gold Standard for REFLUX 2
(Date:9/16/2014)... 2014 Marybeth Cale, owner of Cale ... of Manhattan in the small village of Rhinebeck, New York, ... business. Cale, a mompreneur, has expanded the business to incorporate ... people to maximize potential. Those services will include group trainings ... one-on-one life coaching for clients all over the country. ...
(Date:9/16/2014)... 2014 Operation Smile was founded “on the ... a facial deformity.” To spread their message and mission, the ... at the Beverly Wilshire Hotel in Beverly Hills, California. The ... whose lives have been forever transformed by the efforts of ... with Operation Smile,” said Lynda Erkiletian, Executive Director of The ...
(Date:9/16/2014)... 2014 On Friday, September 12, ... product extensions, an accompanying mobile application, the grand-opening ... tools for their sales force, and their sponsorship ... 5th annual national convention, Rise to Enterprise 2014 ... the Hyatt Regency Orange County was treated to ...
(Date:9/16/2014)... Silver Spring, Md. (PRWEB) September 16, 2014 ... The Road , Free Education Forum for PH Patients and ... Pulmonary Hypertension Association – the country’s leading pulmonary hypertension ... pulmonary hypertension (PH) – a disease of the lungs that ... right heart failure. Without treatment, mean survivability is only 2.8 ...
(Date:9/16/2014)... HealthDay Reporter TUESDAY, Sept. 16, ... spot human papillomavirus (HPV), which is linked to the risk ... shows that testing urine for HPV has good accuracy when ... said lead researcher Dr. Neha Pathak. She is a resident ... University of London, England. The test could be done ...
Breaking Medicine News(10 mins):Health News:Mompreneur Marybeth Cale of Cale Communications Announces Launch Of Life Coaching And Workshop Business 2Health News:James & Paula Coburn Foundation to Host the 2014 Smile Gala, Presented by Operation Smile 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 3Health News:New Products Announced at Jusuru International’s R2E14 National Convention 4Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 3Health News:Urine Test for HPV Works Well, Analysis Finds 2
... driving challenges this time of year, safety group says ... brings plenty of road hazards and challenges: wet leaves, lumbering ... year, September had the second-highest number of deaths per mile ... per 100 million vehicle miles, according to the National Safety ...
... ... year, 35 to 50 million Americans become infected with the flu (influenza). On average, the ... TX is taking steps to combat these preventable deaths by offering free flu shots . ... Plano, TX (Vocus) September 12, 2009 ...
... ... Pappagallo, MD, Present Partnering Primary Care Physicians with Pain Specialists , ... Las Vegas, NV (PRWEB) September 12, 2009 -- PAINWeek® ... CPE, and Dr. Marco Pappagallo, MD, teaching a Master Class that addressed the need for ...
... , , , ... leading provider of kidney care services for those diagnosed with chronic kidney ... series of 5K events raising funds and awareness of CKD across the ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ) , , ...
... The Johns Hopkins Bloomberg School of Public Health has ... Research Program (OETRP) of the U.S. Department of Defense ... Bloomberg School will serve as the coordinating center for ... civilian trauma centers working together with several major military ...
... CHICAGO, Sept. 11 Schofield Media Group has promoted Brian ... U.S. and European operations consisting of five divisions and more than ... in 2006 as executive president, and in 2008 was made group ... made and continues to make a great contribution to the company," ...
Cached Medicine News:Health News:H1N1 frenzy may allow regular flu to be more deadly than ever 2Health News:Need for Pain and Palliative Care Mentorship Addressed at PAINweek 2009 2Health News:DaVita Launches Nationwide Series of Kidney Awareness Run/Walks 2Health News:JHSPH to lead extremity trauma clinical research consortium 2Health News:JHSPH to lead extremity trauma clinical research consortium 3
... Ruschelit® PVC. 2 eyes, oral. ... patient age. X-ray opaque line. Graduated. ... Designed to reduce kinking of the ... Ruschelit® PVC adapts to the anatomical ...
... Set® Tube with stylet inside. Sterile, ... uncuffed Rusch endotracheal tube with a ... use saving you time and storage ... for easy identification and has a ...
... Clear Plus™ Cuffed Endotracheal Tube w. Flexi -Slip™ ... Single use. A quality Rusch endotracheal tube with ... saving you time and storage space. The stylet ... withdrawal. It is designed with a soft distal ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Medicine Products: